Herborium® Announces 4th Quarter Update Record Black Friday and Cyber Monday Sales Bring 15% Revenue Growth in 4th Quarter and Expected Highest Yearly Revenues On Record.

Rhea-AI Summary

Herborium Group Reports Record Revenue Growth

Herborium Group, a botanical therapeutics company, announced a 15% revenue growth in Q4 2021 compared to the previous year, marking its highest yearly sales on record. Strong performance during Black Friday and Cyber Monday, along with increased wholesale orders, contributed to this achievement. Key developments included no dilution in shares, the launch of a new protein bar, and expanded market presence in the US and France. Looking ahead, Herborium aims for further growth through new partnerships and product developments in 2022.

Positive

• 15% revenue growth in Q4 2021 compared to the same period last year.
• Highest yearly sales record in 2021.
• Strong sales during Black Friday and Cyber Monday.
• No dilution in share structure.
• Launch of Herborium Protein Bar into production.
• New management in French market leading to partnerships with pharmacies.
• Expansion into Asian markets.

Negative

• None.

No Dilution in Shares Structure Anticipated

Houston, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Houston, Texas, 12/07/2021. Herborium Group, Inc.  (OTC Pink: HBRM),  a Botanical Therapeutics Company and the provider of unique, all botanical medicinal products with a strong records of efficacy and safety, (Botanical Therapeutics®), and personalized, interactive, medical needs driven content, released today its 4th Quarter results marking 15% revenues growth for the Quarter over the same period last year,  and bringing the Yearly Sales for 2021 to the highest on Record.

Very Successful US and French Markets Black Friday and Cyber Monday sales and an increase in end of the year wholesale orders helped Herborium to close 2021 as the the highest grossing year to date.

The Fourth Quarter of 2021 also marks a number of other milestones:

1.  NO Dilution in share structure
2.  Announcing Crypto-Currency Technology capabilities
3. Herborium Protein Bar goes into production
4. New Management for the French Market brings new partnerships with pharmacies in France
5. Product L Extension Partnership in line for 2022
6. Expansion of Asian Market presence

Herborium’s core business growth in 4^th Quarter creates a strong foundation for further growth in 2022.  New developments together with steady progress in previous initiatives allowed the 4^Th Quarter to advance shareholders value. These initiatives allowed Herborium to immediately expand in current markets and pave the way for entrance into future markets   Herborium’s global presence has expanded in 2021 and contributes to the company having  profitable international partnerships and points to further growth in 2022..  

About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics company that develops, license and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, women’s health and selected sexual disorders and has built the versatile, technologically advanced, interactive content platform to support consumer needs.  Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, www.acnease.com,  www.acnease.fr and www.acneasesp.com

Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed.  The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Attachment

• logo PR

FAQ

What was the revenue growth for HBRM in Q4 2021?

Herborium Group reported a 15% revenue growth in Q4 2021 compared to the same period last year.

What are the key milestones announced by HBRM for 2021?

HBRM announced key milestones including no dilution in shares, production of a new protein bar, and expansion into the Asian market.

Did HBRM experience share dilution in their recent report?

No, Herborium Group confirmed there was no dilution in their share structure.

How did HBRM perform during Black Friday and Cyber Monday?

Herborium experienced very successful sales during Black Friday and Cyber Monday, contributing to their record revenue in 2021.

What are HBRM's plans for 2022?

Herborium plans to expand further in current markets and enter new markets, leveraging new partnerships and product development initiatives.